1
|
Ye J, Bates N, Soteriou D, Grady L, Edmond C, Ross A, Kerby A, Lewis PA, Adeniyi T, Wright R, Poulton KV, Lowe M, Kimber SJ, Brison DR. High quality clinical grade human embryonic stem cell lines derived from fresh discarded embryos. Stem Cell Res Ther 2017; 8:128. [PMID: 28583200 PMCID: PMC5460457 DOI: 10.1186/s13287-017-0561-y] [Citation(s) in RCA: 24] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/15/2017] [Revised: 04/05/2017] [Accepted: 04/11/2017] [Indexed: 12/15/2022] Open
Abstract
BACKGROUND Human embryonic stem cells (hESCs) hold tremendous promise for cell replacement therapies for a range of degenerative diseases. In order to provide cost-effective treatments affordable by public health systems, HLA-matched allogeneic tissue banks of the highest quality clinical-grade hESCs will be required. However only a small number of existing hESC lines are suitable for clinical use; they are limited by moral and ethical concerns and none of them apply Good Manufacturing Practice (GMP) standards to the earliest and critical stages of gamete and embryo procurement. We thus aimed to derive new clinical grade hESC lines of highest quality from fresh surplus GMP grade human embryos. METHODS A comprehensive screen was performed for suitable combinations of culture media with supporting feeder cells or feeder-free matrix, at different stages, to support expansion of the inner cell mass and to establish new hESC lines. RESULTS We developed a novel two-step and sequential media system of clinical-grade hESC derivation and successfully generated seven new hESC lines of widely varying HLA type, carefully screened for genetic health, from human embryos donated under the highest ethical and moral standards under an integrated GMP system which extends from hESC banking all the way back to gamete and embryo procurement. CONCLUSIONS The present study, for the first time, reports the successful derivation of highest-quality clinical-grade hESC lines from fresh poor-quality surplus human embryos generated in a GMP-grade IVF laboratory. The availability of hESC lines of this status represents an important step towards more widespread application of regenerative medicine therapies.
Collapse
Affiliation(s)
- Jinpei Ye
- Division of Cell Matrix Biology and Regenerative Medicine, School of Biology, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Sciences Centre, 46 Grafton Street, Manchester, M13 9NT UK
- North West Embryonic Stem Cell Centre, Central Manchester University Hospitals NHS Foundation Trust and University of Manchester, Oxford Road, Manchester, M13 9WL UK
- Present Address: Institute of Biomedical Sciences, Shanxi University, Taiyuan, China
| | - Nicola Bates
- Division of Cell Matrix Biology and Regenerative Medicine, School of Biology, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Sciences Centre, 46 Grafton Street, Manchester, M13 9NT UK
- North West Embryonic Stem Cell Centre, Central Manchester University Hospitals NHS Foundation Trust and University of Manchester, Oxford Road, Manchester, M13 9WL UK
| | - Despina Soteriou
- Division of Cell Matrix Biology and Regenerative Medicine, School of Biology, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Sciences Centre, 46 Grafton Street, Manchester, M13 9NT UK
- North West Embryonic Stem Cell Centre, Central Manchester University Hospitals NHS Foundation Trust and University of Manchester, Oxford Road, Manchester, M13 9WL UK
| | - Lisa Grady
- Division of Cell Matrix Biology and Regenerative Medicine, School of Biology, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Sciences Centre, 46 Grafton Street, Manchester, M13 9NT UK
- North West Embryonic Stem Cell Centre, Central Manchester University Hospitals NHS Foundation Trust and University of Manchester, Oxford Road, Manchester, M13 9WL UK
| | - Clare Edmond
- Division of Cell Matrix Biology and Regenerative Medicine, School of Biology, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Sciences Centre, 46 Grafton Street, Manchester, M13 9NT UK
- North West Embryonic Stem Cell Centre, Central Manchester University Hospitals NHS Foundation Trust and University of Manchester, Oxford Road, Manchester, M13 9WL UK
| | - Alex Ross
- Department of Reproductive Medicine, Old St Mary’s Hospital, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Sciences Centre, Oxford Road, Manchester, M13 9PW UK
- North West Embryonic Stem Cell Centre, Central Manchester University Hospitals NHS Foundation Trust and University of Manchester, Oxford Road, Manchester, M13 9WL UK
| | - Alan Kerby
- Division of Cell Matrix Biology and Regenerative Medicine, School of Biology, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Sciences Centre, 46 Grafton Street, Manchester, M13 9NT UK
| | - Philip A. Lewis
- Division of Cell Matrix Biology and Regenerative Medicine, School of Biology, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Sciences Centre, 46 Grafton Street, Manchester, M13 9NT UK
| | - Tope Adeniyi
- Department of Reproductive Medicine, Old St Mary’s Hospital, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Sciences Centre, Oxford Road, Manchester, M13 9PW UK
| | - Ronnie Wright
- Genomic Diagnostics Laboratory, Manchester Centre for Genomic Medicine, Saint Mary’s Hospital, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Sciences Centre, Oxford Rd, Manchester, M13 9WL UK
| | - Kay V. Poulton
- Transplantation Laboratory, Manchester Royal Infirmary, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Sciences Centre, 46 Grafton Street, Manchester, M13 9NT UK
| | - Marcus Lowe
- Transplantation Laboratory, Manchester Royal Infirmary, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Sciences Centre, 46 Grafton Street, Manchester, M13 9NT UK
| | - Susan J. Kimber
- Division of Cell Matrix Biology and Regenerative Medicine, School of Biology, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Sciences Centre, 46 Grafton Street, Manchester, M13 9NT UK
- North West Embryonic Stem Cell Centre, Central Manchester University Hospitals NHS Foundation Trust and University of Manchester, Oxford Road, Manchester, M13 9WL UK
| | - Daniel R. Brison
- Department of Reproductive Medicine, Old St Mary’s Hospital, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Sciences Centre, Oxford Road, Manchester, M13 9PW UK
- Maternal and Fetal Health Research Centre, Division of Developmental Biology & Medicine, School of Medicine, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Sciences Centre, 46 Grafton Street, Manchester, M13 9NT UK
- North West Embryonic Stem Cell Centre, Central Manchester University Hospitals NHS Foundation Trust and University of Manchester, Oxford Road, Manchester, M13 9WL UK
| |
Collapse
|